Observational study / 2000
High antibodies to gluten and casein were observed in autism and schizophrenia, and a gluten-casein-free diet was accompanied by symptom improvements.
Researchers analyzed antibody levels and peptide patterns in patients with autism or schizophrenia. High-titer IgG antibodies to gliadin were found in 87% of autistic and 86% of schizophrenic patients, and IgG against bovine casein in 90% and 93%, respectively. Elevated IgA antibodies to gluten or casein appeared in 30% of autistic children, while in schizophrenic patients 86% had elevated IgA to gluten and 67% to casein. When schizophrenic patients received dialysis, a gluten-casein-free diet, or both, peptiduria and Brief Psychiatric Rating Scores fell; in children with autism, a gluten-casein-free diet was accompanied by improvement in 81% within 3 months.
Shows an association, not proof of cause and effect.
- Study type
- Observational and clinical report
- Who was studied
- Children with autism and patients with schizophrenia (sample size not specified)
- What was measured
- Serum IgA and IgG antibodies to gliadin and casein, peptiduria, and behavioral/psychiatric ratings
THE PAPER
Autism and Schizophrenia: Intestinal Disorders.
Cade R, Privette M, Fregly M, Rowland N, Sun Z, Zele V, Wagemaker H, Edelstein C. Nutr Neurosci, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.